JP Morgan Chase’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,900
Closed -$442K 7658
2024
Q3
$442K Hold
1,900
﹤0.01% 4975
2024
Q2
$383K Hold
1,900
﹤0.01% 4823
2024
Q1
$326K Buy
1,900
+400
+27% +$74.6K ﹤0.01% 5067
2023
Q4
$325K Buy
+1,500
New +$257K ﹤0.01% 5055
2023
Q3
Sell
-5,300
Closed -$1.53M 7663
2023
Q2
$1.53M Buy
+5,300
New +$1.61M ﹤0.01% 3741
2018
Q3
Sell
-30,000
Closed -$2.57M 5780
2018
Q2
$2.57M Buy
+30,000
New +$2.69M ﹤0.01% 3211

Other funds holding PODD

JP Morgan Chase's PODD Position: Q1 2026 in Review

JP Morgan Chase increased its Insulet (PODD) stake by 17% in Q1 2026, buying an estimated $10.6M and bringing the position to 287,153 shares worth $59.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

JP Morgan Chase first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $534M in Q2 2023. 785 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • JP Morgan Chase held 287,153 shares of Insulet worth $59.7M as of Q1 2026.
  • JP Morgan Chase bought 42,322 Insulet shares in Q1 2026, an estimated $10.6M.
  • Insulet made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1273 holding.
  • JP Morgan Chase first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Insulet position peaked at $534M in Q2 2023.
  • 785 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.